Academic Journal

P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES

التفاصيل البيبلوغرافية
العنوان: P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES
المؤلفون: M. Gertz, A. Cohen, R. Comenzo, E. Kastritis, H. Landau, E. Libby, M. Liedtke, V. Sanchorawala, S. Schönland, A. Wechalekar, Y. Ando, Y. Koh, J. Zonder, G. Palladini, C. Nie, C. Karp, Y. Jin, A. Conrad, G. Kinney, G. Merlini
المصدر: HemaSphere, Vol 7, Iss S2, Pp 41-42 (2023)
بيانات النشر: Wiley
سنة النشر: 2023
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 2572-9241
Relation: http://journals.lww.com/10.1097/01.HS9.0000936352.84768.4d; https://doaj.org/toc/2572-9241; https://doaj.org/article/8702a2d63e6f4b10b911e3eaeffb4736
DOI: 10.1097/01.HS9.0000936352.84768.4d
الاتاحة: https://doi.org/10.1097/01.HS9.0000936352.84768.4d
https://doaj.org/article/8702a2d63e6f4b10b911e3eaeffb4736
رقم الانضمام: edsbas.2A4E74AF
قاعدة البيانات: BASE
الوصف
تدمد:25729241
DOI:10.1097/01.HS9.0000936352.84768.4d